We sell decisions, not modules.
A product list tells you what software does. It does not tell you what changes on Monday. Whatever your industry calls them, every engagement we run is aimed at one of four outcomes — and each one names the measure it is judged on.
Put money where it returns
Investment choices — which molecule to develop, which line to commission, which programme to fund, which deal to chase — are usually made with good instincts and bad evidence. We give the choice a rubric, the data to score against it, and a signed record of who decided what.
Judged on: decision cycle time, and spend avoided on options that should not have been funded.
See the slip before it lands
Delivery data is almost always backward-looking: what was produced, what was billed, what was missed. We turn the same data forward — capacity against committed load, effort against plan, vendor reliability against promise — so a problem arrives as a warning rather than an apology.
Judged on: on-time performance, and how many days of warning you get before a slip.
Protect the margin you sold
Margin is lost in small places — a quote priced without current costs, a change absorbed to keep a client happy, an invoice raised late. Putting quote, delivery, billing and collection on one chain makes each of those visible while it is still reversible.
Judged on: gross margin, invoice cycle time and days sales outstanding.
Be ready for the inspection
In pharma, and any business audited by its customers, being right is not enough — you have to be able to show it. Evidence produced as work happens costs almost nothing. Evidence assembled for an inspection costs weeks.
Judged on: audit-pack preparation time, and how many findings relate to documentation rather than practice.
The same four ideas, in five vocabularies.
Solutions are not separate from industries — they are the outcome you are buying, expressed in your industry's own words. Follow the row you belong to.
| Industry | Decide | Deliver | Earn | Prove |
|---|---|---|---|---|
| Manufacturing | Capex and line investment | Delivery risk and OTIF | Quote to cash, job margin | Customer audit evidence |
| Pharmaceutical | Molecule selection | NPD stage gates | Development spend control | Part 11 and CSV |
| IT services | Portfolio and bid choice | Schedule and effort variance | Project P&L and DSO | Client and SLA reporting |
| Staffing | Which accounts to invest in | Fill rate and bench | Margin per placement | Statutory and client audit |
| Education | Programme and funding allocation | Programme milestones | Fund utilisation | Verified credentials |
Outcomes are the point. Products are how we reach them.
Every outcome above is delivered by one of three built systems — ProjectX, PharmX or EduX — configured to your industry. If you would rather start from the tool than the outcome, the products page is the other door into the same place.
Which outcome is costing you most?
Answer four questions and get a written brief on which of the four we would target first, and how.